In this third workshop, you are invited back to share your valuable insights, solutions and opinions for reducing pharmaceutical residuals in the Baltic Sea region
The hybrid workshop will focus on a comparative analysis and an assessment of possibilities according to the specific characteristics of the Baltic countries. As a participant, you will expand your own knowledge, collaborate, share and compare techniques to prevent and reduce the residuals as early in the process as possible.
Date: 9 February 2023
Time: 11.00–15.05 EET
Location: (Hybrid) Zoom and in Kastytis room at Technopolis Nova building, V. Gerulaičio g. 10, Vilnius (Lithuania)
Participation is free of charge. To take part, please pre-register through the host LBTA by clicking below:
Agenda
10.30–11.00 Registration, welcome coffee/tea (physical venue)
11.00–11.10 Opening, setting the scene
Session 1: Collection and handling of pharmaceutical residues
11.10–11.30 Current state in Lithuania and in Estonia
Representatives of the Lithuanian Biotechnology Association and ScanBalt BioRegion, Northern Europe's network for innovation in health and in life-sciences based in Estonia.
Representatives of the Lithuanian Biotechnology Association and ScanBalt BioRegion, Northern Europe's network for innovation in health and in life-sciences based in Estonia.
11.30–11.50 Developments at the EU level
Adrian van den Hoven, Director General, Medicines for Europe. Association representing the generic, biosimilar and value-added medicines industries across Europe, Belgium.
Session 2: Solutions for preventing and handling pharmaceutical residues throughout the chain
11.50–12.10 Case of pharmaceutical company
Peter Gruvstedt, AstraZeneca’s Wastewater Treatment Plant based in Sweden
Peter Gruvstedt, AstraZeneca’s Wastewater Treatment Plant based in Sweden
12.10–12.40 Case of solution providers
Vytautas Abromaitis, YAQUATEC. Company developing advanced treatment technologies to remove pharmaceutical residuals from wastewater, Lithuania.
Anna Herslow Lind, Paxxo. Company developing solutions for an efficient waste system which is both climate-smart and hygienical, Sweden.
Vytautas Abromaitis, YAQUATEC. Company developing advanced treatment technologies to remove pharmaceutical residuals from wastewater, Lithuania.
Anna Herslow Lind, Paxxo. Company developing solutions for an efficient waste system which is both climate-smart and hygienical, Sweden.
12.40–13.00 Joint discussion on bottlenecks and gaps
13.00–14.00 Networking launch (physical venue)
Session 3: Cross-national cooperation on pharmaceuticals in the environment: Achievements and future opportunities
14.00–14.20 Lithuanian-Latvian collaboration on pharmaceuticals in wastewaters – Levels, impacts and reduction
Sergej Suzdalev, Klaipėda University Marine Research Institute, Lithuania.
Sergej Suzdalev, Klaipėda University Marine Research Institute, Lithuania.
14.20–14.40 Examples of Nordic solutions for reducing pharmaceutical residuals
Caroline Charlier, TEM/Nordic Center for Sustainable Healthcare, Sweden
Linus Karlsson, IVL Swedish Environmental Research Institute
Caroline Charlier, TEM/Nordic Center for Sustainable Healthcare, Sweden
Linus Karlsson, IVL Swedish Environmental Research Institute
14.40–15.00 Joint discussion on a roadmap for reducing pharmaceutical residuals in the Baltic Sea region
15.00–15.05 Closing words
The project "Closing gaps: Techniques and solutions for reducing pharmaceutical residuals in the Baltic Sea region" is funded by the Swedish Institute.
